SS
HZNP

Simplicity Solutions’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Simplicity Solutions’s Portfolio HZNP Stock Details HZNP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-4,164
Closed -$482K – 1121
2023
Q3 		$482K Sell
4,164
-357
-8% -$38.4K 0.02% 607
2023
Q2 		$465K Buy
4,521
+1,052
+30% +$111K 0.01% 686
2023
Q1 		$379K Buy
3,469
+1,551
+81% +$171K 0.01% 773
2022
Q4 		$218K Buy
+1,918
New +$159K 0.03% 591

Other funds holding HZNP

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
VWA
Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return
FSWA
Financial Synergies Wealth Advisors Houston, Texas $1.18B AUM 31.41% 1-Year Est. Return
BCMLT
Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Simplicity Solutions's HZNP Position: Q4 2023 in Review

Simplicity Solutions sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,164 shares — an estimated $482K sold.

Simplicity Solutions first reported a position in HZNP in Q4 2022 and held it in 4 quarters. The position peaked at $482K in Q3 2023. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

  • Simplicity Solutions reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Simplicity Solutions sold 4,164 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $482K.
  • Simplicity Solutions first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2022 and held it in 4 quarters.
  • Simplicity Solutions's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $482K in Q3 2023.
  • 6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Simplicity Solutions's 13F filing for Q4 2023, filed 29 Jan 2024.